Structural insights into heterohexameric assembly of epilepsy-related ligand-receptor complex LGI1-ADAM22
Takayuki YamaguchiiD, Kei OkatsuiD, Masato Kubota, Ayuka Mitsumori, Atsushi YamagataiD, Yuko FukataiD, Masaki FukataiD, Mikihiro ShibataiD, Shuya FukaiiD
Abstract
Leucine-rich glioma-inactivated 1 protein (LGI1) is a secreted neuronal protein consisting of the N-terminal leucine-rich repeat (LRR) and C-terminal epitempin repeat (EPTP) domains. LGI1 is linked to epilepsy, a neurological disorder that can be caused by genetic mutations of genes regulating neuronal excitability (e.g., voltage- or ligand-gated ion channels). ADAM22 is a membrane receptor that binds to LGI1 extracellularly and interacts with AMPA-type glutamate receptors via PSD-95 intracellularly to maintain normal synaptic signal transmission. Structural analysis of the LGI1-ADAM22 complex is important for understanding the molecular mechanism of epileptogenesis and developing new therapies against epilepsy. We previously reported the crystal structure of a 2:2 complex consisting of two molecules of LGI1 and two molecules of the ADAM22 ectodomain (ECD), which is suggested to bridge neurons across the synaptic cleft. On the other hand, multiangle light scattering, small-angle X-ray scattering, and cryo-EM analyses have suggested the existence of a 3:3 complex consisting of three molecules of LGI1 and three molecules of ADAM22. In the previous cryo-EM analysis, many observed particles were in a dissociated state, making it difficult to determine the three-dimensional (3D) structure of the 3:3 complex. In this study, we stabilized the 3:3 LGI1-ADAM22ECD complex using chemical crosslinking and determined the cryo-EM structures of the LGI1LRR-LGI1EPTP- ADAM22ECD and 3:3 LGI1-ADAM22ECD complexes at 2.78 [A] and 3.79 [A] resolutions, respectively. Furthermore, high-speed atomic force microscopy (HS-AFM) visualized the structural features and flexibility of the 3:3 LGI1-ADAM22ECD complex in solution. We discuss new insights into the interaction modes of the LGI1-ADAM22 higher-order complex and the structural properties of the 3:3 LGI1-ADAM22 complex. SignificanceThe neuronal secretory protein Leucine-rich glioma-inactivated 1 (LGI1) and its receptor protein ADAM22 play a critical role in maintaining normal synaptic signal transmission. Genetic mutations in LGI1 are linked to epilepsy. Structural analysis of the LGI1-ADAM22 complex is crucial for understanding the molecular mechanisms of epileptogenesis and for developing targeted treatments. In this study, we determined the cryo-EM structure of the heterohexameric LGI1-ADAM22 complex and visualized the dynamics of this complex by high-speed atomic force microscopy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.40
- Field percentile
- top 45%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leucine-rich glioma inactivated 1 is a ganglioside-binding protein
Kévin Debreux, Christian Lévêque, … Oussama El Far·bioRxiv·Feb 8, 2026
- An epitope specific patient-derived LGI1-autoantibody enhances neuronal excitability by modulating the Kv1.1 channel.
Johanna Extrémet, Oussama El Far, … Michaël Russier·bioRxiv·Dec 10, 2021
- LGI1 downregulation increases neuronal circuit excitability
Eleonora Lugarà, Rahul Kaushik, … Matthew C. Walker·EpilepsiaPeer-reviewed·Oct 26, 2020
- Patient-derived recombinant autoantibodies reveal the subcellular neuroglial distribution and heterogeneous interactome of leucine-rich glioma-inactivated 1
Jorge Ramírez‐Franco, Kévin Debreux, … Oussama El Far·bioRxiv·Mar 29, 2022
- Activity-driven synaptic translocation of LGI1 controls excitatory neurotransmission
Ulku Cuhadar, Lorenzo Calzado-Reyes, … Jaime de Juan‐Sanz·Cell ReportsPeer-reviewed·Jan 1, 2022
- LGI1 autoantibodies enhance synaptic transmission by presynaptic Kv1 loss and increased action potential broadening
Andreas Ritzau‐Jost, Felix Gsell, … Stefan Hallermann·Neurology Neuroimmunology & NeuroinflammationPeer-reviewed·Aug 14, 2024